| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |